{"meta":{"query_hash":"8dd782c58eec","filters":{"venue":"Multiple Sclerosis and Demyelinating Disorders"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8dd782c58eec","api":"https://metacan.xera.ac/api/v1/cohort?venue=Multiple+Sclerosis+and+Demyelinating+Disorders"},"results":[{"id":"W2469682076","doi":"10.1186/s40893-016-0014-y","title":"Longitudinal change in Paced Auditory Serial Addition Test (PASAT) performance following immunoablative therapy and haematopoietic stem cell transplant in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Demyelinating Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Montreal Neurological Institute and Hospital; University of Ottawa","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Stem cell; Medicine; Paced Auditory Serial Addition Test; Test (biology); Audiology; Physical medicine and rehabilitation; Psychology; Cognition; Biology; Psychiatry; Cognitive impairment","score_opus":0.09101395282567182,"score_gpt":0.2671003416977985,"score_spread":0.1760863888721267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469682076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991061,0.00026276032,0.00006285042,0.000025626488,0.000005774795,0.000017323287,0.00011027678,0.000008277536,0.000400986],"genre_scores_gemma":[0.99898726,0.00010619507,0.000065867374,0.000023852806,0.000006775978,0.000012525833,0.00034516663,0.0000021704634,0.00045030538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996038,0.000082837025,0.000041813702,0.000060814502,0.00013220475,0.000078527526],"domain_scores_gemma":[0.9978752,0.00024955574,0.00088488776,0.00010345884,0.0003507218,0.0005361601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011396979,0.00033957182,0.00044917027,0.0005516806,0.000422638,0.00046876847,0.00032891243,0.0005589627,0.00079275586],"category_scores_gemma":[0.0028950816,0.0001816743,0.00033981632,0.00051687943,0.00024729085,0.00038848142,0.00029733955,0.0009993007,0.00044052585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037507506,0.0014551147,0.97378564,0.000038785183,0.00015787703,0.00081583177,0.00043518245,0.00024270445,0.0049605067,0.000020559268,0.00026519707,0.014071702],"study_design_scores_gemma":[0.000018367113,0.0022121158,0.99648666,0.000005070783,0.00003758146,0.00038901393,0.000038923656,0.00013673767,0.0004957875,0.000015806014,0.0001581053,0.0000057722805],"about_ca_topic_score_codex":0.003575996,"about_ca_topic_score_gemma":0.0040948195,"teacher_disagreement_score":0.003575996,"about_ca_system_score_codex":0.00036848968,"about_ca_system_score_gemma":0.0003757743,"threshold_uncertainty_score":0.007110417},"labels":[],"label_agreement":null},{"id":"W2617486356","doi":"10.1186/s40893-017-0026-2","title":"Baseline characteristics associated with NEDA-3 status in fingolimod-treated patients with relapsing-remitting multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Demyelinating Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux","keywords":"Fingolimod; Medicine; Multiple sclerosis; Natalizumab; Expanded Disability Status Scale; Hazard ratio; Internal medicine; Magnetic resonance imaging; Proportional hazards model; Relapsing remitting; Disease; Confidence interval; Radiology","score_opus":0.04654221766056195,"score_gpt":0.2630757788459848,"score_spread":0.21653356118542288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617486356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994832,0.00016942796,0.000033413547,0.000018951765,0.0000028222041,0.00000484849,0.0001493448,0.0000011702402,0.00013662277],"genre_scores_gemma":[0.9995585,0.000051761486,0.000033031134,0.000016697224,0.000006478654,0.0000078057055,0.00025576467,8.457703e-7,0.00006912338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954176,0.000139779,0.00006905817,0.00010080922,0.000072599774,0.000076001015],"domain_scores_gemma":[0.997288,0.0009423708,0.001093567,0.0001538634,0.00010995219,0.00041229068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007126229,0.00017297849,0.00048673025,0.0005323138,0.00035067872,0.00049270666,0.00027997573,0.00063693285,0.0009914284],"category_scores_gemma":[0.0030747398,0.0002019913,0.000394447,0.0007801616,0.00030456626,0.00045218092,0.00028727748,0.0008205418,0.00024296978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006173639,0.000059819104,0.9982206,0.0000067863702,0.000040786937,0.00011677972,0.000036173427,0.000057914778,0.00019436011,0.00000776238,0.000033587687,0.0006080836],"study_design_scores_gemma":[0.000021609985,0.00023713282,0.99913293,0.0000032211146,0.000016676877,0.00022695297,0.00005676525,0.00017960941,0.00003028895,0.000019730176,0.0000708498,0.0000041156627],"about_ca_topic_score_codex":0.0015394042,"about_ca_topic_score_gemma":0.0013418576,"teacher_disagreement_score":0.0015394042,"about_ca_system_score_codex":0.00024905198,"about_ca_system_score_gemma":0.0002794389,"threshold_uncertainty_score":0.003768742},"labels":[],"label_agreement":null}]}